Herbalife Ltd header image

Herbalife Ltd

HLF

Equity

ISIN KYG4412G1010 / Valor 2002103

CTA NASDAQ OMX Stock Exchange (2024-11-18)
USD 7.88-0.57%

Herbalife Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Herbalife Ltd is a global health and wellness company that offers a variety of science-based products, including weight management, supplements, and personal care items, designed to promote a healthy lifestyle. These products are distributed exclusively through Herbalife Independent Distributors, who provide personalized coaching and motivation to help customers achieve their health goals. Herbalife operates multiple innovation and manufacturing facilities worldwide, focusing on personalization and working closely with their distributors to meet customer needs. The company's product line includes meal replacement shakes, teas, supplements, sports hydration, and personal care products. Herbalife also has a Global Consumer Safety team available to address any product-related inquiries from healthcare providers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (20.08.2024):

Net Sales

Herbalife Ltd. reported net sales of $1.3 billion for the second quarter of 2024, reflecting a 2.5% decrease compared to the same period in 2023. This decline was primarily due to 270 basis points of foreign exchange headwinds. However, on a constant currency basis, net sales saw a slight increase of 0.2% year-over-year, driven by growth in Latin America, EMEA, and Asia Pacific regions.

Net Income

For the second quarter of 2024, Herbalife Ltd. achieved a net income of $4.7 million. When adjusted for certain items, the adjusted net income was significantly higher at $54.8 million. The company faced headwinds from restructuring program expenses and a loss on extinguishment of debt, which impacted the reported net income figures.

Adjusted EBITDA

Herbalife Ltd.'s adjusted EBITDA for the second quarter of 2024 was $180.0 million, surpassing the company's guidance. This figure represents a year-over-year increase in the adjusted EBITDA margin by 120 basis points, reaching 14.1%. The company attributed this performance to improved operational efficiencies and cost management.

Cash Flow and Capital Expenditures

During the second quarter of 2024, Herbalife Ltd. generated $102.5 million in net cash from operating activities. The company also reported capital expenditures of approximately $36 million for the same period. For the full year of 2024, Herbalife expects total capital expenditures to range between $120 million and $150 million.

Outlook and Guidance

Herbalife Ltd. has provided guidance for the third quarter of 2024 and revised its full-year 2024 outlook. The company has reduced its net sales guidance but raised its adjusted EBITDA guidance for the full year. Capital expenditures for the year are expected to remain within the previously stated range, reaffirming the company's commitment to strategic investments.

Summarized from source with an LLMView Source

Key figures

-38.4%1Y
-80.6%3Y
-82.1%5Y

Performance

65.2%1Y
59.5%3Y
54.6%5Y

Volatility

Market cap

1821 M

Market cap (USD)

Daily traded volume (Shares)

135,474

Daily traded volume (Shares)

1 day high/low

7.99 / 7.69

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Emeis
Emeis Emeis Valor: 132546338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.36%EUR 6.11
LifeStance Health Group Inc
LifeStance Health Group Inc LifeStance Health Group Inc Valor: 111701745
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.82%USD 7.01
FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.81%USD 0.34
BeiGene Ltd
BeiGene Ltd BeiGene Ltd Valor: 30165310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.81%USD 187.69
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.14%CHF 110.65
Sonova Holding Ltd.
Sonova Holding Ltd. Sonova Holding Ltd. Valor: 1254978
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.54%CHF 316.90
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.65%CHF 358.00
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.50%CHF 32.74
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.03%CHF 48.00
Evolva Holding LTD
Evolva Holding LTD Evolva Holding LTD Valor: 126205578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-10.68%CHF 0.82